Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer
Clinical trial NCT03348098 · UNKNOWN
Trial details
- NCT number
- NCT03348098
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2018-07-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.